Case-Control Pilot Study on Acute Diarrheal Disease in a Geographically Defined Pediatric Population in a Middle

Ana E Farfán-García1, Chengxian Zhang2, Aamer Imdad2,3

  • 1Grupo de Investigación en Manejo Clínico (CliniUDES), Programa de Bacteriología y Laboratorio Clínico, Facultad de Ciencias de la Salud, Universidad de Santander (UDES), Bucaramanga, Colombia.

Insights

A study in Colombia found that enteroaggregative E. coli, Norovirus, and Salmonella were the most common causes of acute diarrheal disease (ADD) in young children. Comprehensive pathogen detection is crucial for understanding ADD etiology in low-income settings.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Acute diarrheal disease (ADD) is a significant cause of illness and death in children under five.
  • Limited pathogen detection in low- and middle-income countries hinders understanding of ADD causes.
  • A comprehensive approach is needed to identify enteric pathogens in children with ADD.

Purpose of the Study:

  • To assess the feasibility of a detailed case-control study for surveying diarrheal pathogens.
  • To identify common enteropathogens in children with and without moderate-to-severe ADD in Bucaramanga, Colombia.

Main Methods:

  • Utilized microbiology and molecular techniques for detecting viral, bacterial, and parasitic enteropathogens.
  • Conducted a case-control study involving 90 children under five (45 cases, 45 controls).
  • Obtained Institutional Review Board approval and informed consent from guardians.

Main Results:

  • 40% of the 90 children studied tested positive for at least one enteropathogen.
  • Enteropathogens were detected in 44.4% of cases and 35.5% of controls.
  • Enteroaggregative E. coli (10.0%), Norovirus (6.7%), and Salmonella spp. (5.6%) were the most prevalent pathogens.

Conclusions:

  • Enteroaggregative E. coli was the most frequent pathogen, accounting for 18.8% of all infections.
  • A significant proportion (50%) of ADD cases did not show detectable pathogens.
  • Comprehensive pathogen surveillance is feasible and necessary for understanding ADD in diverse settings.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
499
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
359
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
190